232417 HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S

Wednesday, November 10, 2010 : 11:20 AM - 11:45 AM

Louise Haynes, MSW , Division of Clinical Neuroscience, Medical University of South Carolina, Charleston, SC
     
Drug treatment is HIV prevention, and preventing HIV/AIDS is a significant problem for patients seeking treatment for SUD and for the practitioners who see them. Dr. Metsch recently completed a multi-site trial that demonstrated important practical approaches to bringing HIV rapid testing into drug abuse treatment practices. The trial enrolled more than 1200 patients across the country, and one program from the trial has begun the process of adoption of HIV testing.

Learning Areas:
Other professions or practice related to public health
Protection of the public in relation to communicable diseases including prevention or control
Public health or related public policy
Public health or related research
Social and behavioral sciences

Learning Objectives:
Describe the translational research activities of the NIDA Clinical Trials Network, particularly those done in partnership with SAMHSA Discuss rapid HIV testing in substance abuse programs; 1 of the "blending products" developed from research trials sponsored by the NIDA Clinical Trials Network Discuss the NIDA/SAMHSA "fast track" initiative to bring evidence-based treatments into clinical practice more quickly

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Study co-investigator
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 5091.0: 25th Anniversary of Alcohol Tobacco & Other Drugs Section and 10th Anniversary of the NIDA Clinical Trials Network: Progress Together